The Duke Hematology-Oncology Fellowship program provides clinical, translational, and basic laboratory training in hematology, medical oncology, cell therapy and bone marrow transplantation. Program resources include more than 100 full-time faculty in the Divisions of Medical Oncology, Hematological Malignancies and Cellular Therapy, and Hematology. The Fellowship has an average of 21 fellows in different stages of training.

Mission

Program Leadership

Riedel_ 235
Richard F. Riedel, MD
Program Director, Hematology-Oncology Fellowship
Associate Professor of Medicine 
Division of Medical Oncology
Duke University Medical Center
Email: richard.riedel@duke.edu 
G. Arepally_ 235x300
Gowthami M. Arepally, MD
Associate Program Director, Hematology-Oncology Fellowship
Professor of Medicine and Pathology
Division of Hematology
Duke University Medical Center
Email: gowthami.arepally@duke.edu
Andrea S 235x300
Andrea Sitlinger, MD
Associate Program Director, Hematology-Oncology Fellowship
Assistant Professor of Medicine
Division of Hematology
Member of the Duke Cancer Institute
Email: andrea.sitlinger@duke.edu

Nyasia Lloyd
Program Coordinator, Hematology-Oncology Fellowship
Phone: 919-684-2287
Email: nyasia.lloyd@duke.edu

Latest News

Gastroenterology fellow Zachary S. Lorsch, and Katherine Zhao, a hematology-oncology fellow in the Duke Department of Medicine (DOM) are recipients of the American Society for Clinical Investigation (ASCI) 2025 Early-Career Awards.
A new cohort of 17 Faculty Development Academy (FDA) members kicked off the academic year on September 26 under the director of Department of Medicine Vice Chair for Faculty Development,  Dr. Carla Brady.

Dr. Stefanie Sarantopoulos grew up in the Connecticut textile mill town of Danielson, where her Greek immigrant grandparents settled.

The Duke Department of Medicine joined thousands across the country on Wednesday, November 29 for the 2023 Fellows Match Day. Duke Internal Medicine residents gathered in Duke North 2002 with excitement to learn where their educational journey would take them next as they continue to move medicine forward.